Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ahhh moonie, please don't pick up your toys and leave. We wanna hear more from you. Please share your intimate knowledge of how the pill sniffer works and how revolutionary (change the world doncha know) the meth sniffer will be once it hits the open market.
Go CDEX
Is it live, is it Memorex or is it Captain Mike White?
It's so obvious Pookster/Cap'n what you are all about.
Go CDEX. Load the wagon up on Monday..the train is leaving the station and you don't wanna get left behind. We have technology that can change the world. Bill Gates might be interested in investing millions..remember, technology that can change the world and we have it!
Pookster, are you a frustrated investor? LOL You sure act like it.
Go CDEX
Ummm, pookie, do you NOT have any shame whatsoever for your disingenuous "due dilligence" that you spews forth from your "barber shop" school of investing. LOL
Go CDEX
I'm confused Crow what does this mean??
No doubt you are confused pookster..it's evident with every post
I still think there is more to this than meets the eye..
I bet you do pookster! You twist, distort and spin any piece of information you can find on CDEX in an attempt to help you justify having made such a poor investing decision by having a "large" amount of cash invested in CDEX. Yeah, that's it..there's more than meets the eye here alright and it sure ain't the settlement agreed to by both sides in an U.S. District Court LOL.
Looks like the mini-pump is over for CDEX. Where is the good cap'n when you need him?
CDEX INC CL A (OTC BB:CEXI.OB) Delayed quote data
Last Trade: 0.40
Trade Time: 1:11PM ET
Change: Down 0.07 (14.89%)
Prev Close: 0.47
Open: 0.47
Bid: 0.40 x 5000
Ask: 0.47 x 5000
1y Target Est: N/A
Day's Range: 0.40 - 0.47
52wk Range: 0.38 - 1.33
Volume: 20,613
Avg Vol (3m): 35,866.2
Market Cap: 14.71M
P/E (ttm): N/A
EPS (ttm): -0.14
Div & Yield: N/A (N/A)
Here's the bottom line with CDEX today.
CDEX INC CL A (OTC BB:CEXI.OB) Delayed quote data Edit
Last Trade: 0.39
Trade Time: 9:30AM ET
Change: Down 0.02 (4.88%)
Prev Close: 0.41
Open: 0.39
Bid: 0.39 x 5000
Ask: 0.41 x 5000
1y Target Est: N/A
Day's Range: 0.39 - 0.39
52wk Range: 0.38 - 1.33
Volume: 379
Avg Vol (3m): 31,284.6
Market Cap: 14.35M
P/E (ttm): N/A
EPS (ttm): -0.14
Div & Yield: N/A (N/A)
Yeah boy! Go CDEX!
The only pain I am experiencing is having to read through your endless tripe about this "world changing company" LOL
It's great that you are a company shill and believe that this so called technology is going to change the world...but..are the shareholders gonna get rich or..are they gonna be left holding the bag while the insiders and shills try to pump and dump.
You can keep you primary domicile in FLA even when you file for bankruptcy CAP. CDEX will certainly be changing your world ..not exactly like you figured I guess.
Go CDEX!
Wow Cap, just 21 minutes before you chime in with more of your hype. You appear to be an ever vigilent company shill always ready for the company rebuttal regardless of CDEX's abysmal current PPS and low trading volume and most likely questionable or significant revenue due in their upcoming SEC filing.
Go CDEX
Looks like Capnmike's hyping and spamming is moving the PPS in the wrong direction: LOL
CDEX INC CL A (OTC BB:CEXI.OB) Delayed quote data
Last Trade: 0.39
Trade Time: 3:57PM ET
Change: Down 0.02 (4.88%)
Prev Close: 0.41
Open: 0.39
Bid: 0.39 x 5000
Ask: 0.40 x 5000
1y Target Est: N/A
Day's Range: 0.39 - 0.42
52wk Range: 0.38 - 1.33
Volume: 25,187
Avg Vol (3m): 35,923.4
Market Cap: 14.35M
P/E (ttm): N/A
EPS (ttm): -0.14
Div & Yield: N/A (N/A)
The only thing missing from this scam are posts spewed forth by an individual poster using a moniker related to a ex charter boat captain from Sarasota, Fl. Wonder if he missed out on this opportunity.
Exactly what do you add to any message forums other than your shameless hyping and grasping at anything no matter how unrelated to CDEX to try and pump up this stock?
What's the matter pookster..got a bunch of your customers over at the ole barber shop to buy into this mess and now are scrambling to save face with your shameless postings and drivel.
How far into negative terrority are you pookster? Gonna take a PPS of how much to get you into the green? You smell up these forums with your hyping and disingenuous discourses into subjects that you have little or no knowledge.
Go CDEX!
See the vermin run and obfuscate when the light is cast upon their lies and deception. The promoter from Sarasota is running scared..keep up the pressure Demmo47 and Diddy. Make the promoter from Sarasota jump through some hoops..losing one's life savings will make any rodent uncomfortable.
Diddy, we don't know each other but I 'like' the way you think and enjoy your posts. Thanks for being a breath of fresh air here and in the other heavily contaminated forums that you post in. Vermin such as Capnmike and Monsoonman can't stand the light being shined upon them as they continue to obfuscate and stretch the truth about CDEX.
Edit: I should have added that rodent-like Paige/Pookie to the list of vermin shamelessly hyping and mis-representing CDEX
CDEX INC CL A (OTC BB:CEXI.OB) Delayed quote data
Last Trade: 0.42
Trade Time: 1:25PM ET
Change: Down 0.03 (6.67%)
Prev Close: 0.45
Open: 0.45
Bid: 0.42 x 5000
Ask: 0.45 x 5000
1y Target Est: N/A
Day's Range: 0.42 - 0.45
52wk Range: 0.38 - 1.33
Volume: 17,558
Avg Vol (3m): 38,657.1
Market Cap: 15.45M
P/E (ttm): N/A
EPS (ttm): -0.14
Div & Yield: N/A (N/A)
CDEX INC CL A (OTC BB:CEXI.OB) Delayed quote data
Last Trade: 0.42
Trade Time: 1:25PM ET
Change: Down 0.03 (6.67%)
Prev Close: 0.45
Open: 0.45
Bid: 0.42 x 5000
Ask: 0.45 x 5000
1y Target Est: N/A
Day's Range: 0.42 - 0.45
52wk Range: 0.38 - 1.33
Volume: 17,558
Avg Vol (3m): 38,657.1
Market Cap: 15.45M
P/E (ttm): N/A
EPS (ttm): -0.14
Div & Yield: N/A (N/A)
Why would you need a 3rd party to post a sworn affidavit that you supposedly have given?
Agarrate los huevos and post your affidavit here Capnmike with your own hand, cobarde!
Who asked you moonie?
Surely one can reasonably assume that you might be CDEX company shill based upon your past behaviour..kinda like the good capn mike w.
So sorry Capnmike..I should have said paid stock promoter.
You know that saying "if the shoe fits" LOL
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-KSB
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended October 31, 2005
[_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period From _____ to ____
Commission File Number 000-49845
CDEX INC.
(Exact name of small business issuer in its charter)
CDEX SHAREHOLDERS WILL EXPERIENCE SIGNIFICANT DILUTION IF WE ISSUE ADDITIONAL EQUITY TO FUND OPERATIONS OR ACQUIRE BUSINESSES OR TECHNOLOGIES.
If working capital or future acquisitions are financed through the issuance of equity securities, CDEX shareholders will experience significant dilution. In addition, securities issued in connection with future financing activities or potential acquisitions may have rights and preferences senior to the rights and preferences of the currently outstanding CDEX shares of common stock. The conversion of future debt obligations into equity securities could also have a dilutive effect on our shareholders. Regardless of whether our cash assets prove to be inadequate to meet our operational needs, we may elect to compensate providers of services by issuing stock in lieu of cash.
The ever vigilent company shill.
It's certainly will be less painful for you Capmike when you declare bankruptcy.. at least you get to keep your primary residence. It's terribly distressing to see one lose their life's savings on such a poor investment choice.
Is CDEX financially solvent for the current month of July 2006?
Form 10QSB for CDEX INC
14-Jun-2006
Quarterly Report
Excerpted
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATION
You should read the following discussion in conjunction with our unaudited financial statements and related notes included elsewhere in this document. The following discussion, as well as other discussions in this document, contains forward-looking statements. Please see Forward-Looking Statements for a discussion of uncertainties, risks and assumptions associated with these statements.
To date, CDEX has incurred substantial losses, and will require financing for working capital to meet its operating objectives. We anticipate that we will require financing on an ongoing basis unless and until we are able to support our operating activities with additional revenues.
As of April 30, 2006, we had negative working capital of $184,237, including $86,698 of cash and cash equivalents. We anticipate the need to raise approximately $3,000,000 over the next eighteen months to satisfy our current budgetary projections. Our continued operations, as well as the implementation of our business plan, therefore will depend upon our ability to raise additional funds through bank borrowings, equity or debt financing. If the company is not successful in raising the working capital, it may default in its payments to its creditors and could result in the filing of bankruptcy protection. Currently, the company has sufficient cash to fund operations through the end of June 2006. The company is actively seeking new investments from its current accredited investors as well as new accredited investors.
Prospective investors..Do ya think that CDEX will be able to clear all the hurdles and market their 'fabulous meth gun' sucessfully?
Missouri Meth Announcement subject to CDEX report listed below
Form 10QSB for CDEX INC
14-Jun-2006
Quarterly Report
Excerpted
The Meth Gun is transitioning from a marketing demonstrator prototype, to a beta-test product with a bona-fide law enforcement agency in the Missouri State Highway Patrol, acting as a committed beta-test partner for CDEX. CDEX management anticipates that the "Illicit Drug Detector" could become a significant product portfolio for the company over the next five (5) years. In order for the company to take this product through a successful beta-test program, revise its design, start up a production line, and introduce it into the market by Q2 2007, CDEX must receive additional investment to implement its business plan, successfully complete the pilot test program with MSHP, establish a national and international reseller and distribution network, and enter into production. This will require investment to fund the production start up, marketing and sales initiatives, and provide working capital in order to purchase production materials and parts inventories. If the company is unable to obtain the required funding that it needs through debt or equity financing, in the near term, the potential of the "Illicit Drug Detector" product portfolio cannot be realized.
Wondering about the viability of the "CDEX Meth Gun"
Missouri Meth Announcement subject to CDEX report listed below
Form 10QSB for CDEX INC
14-Jun-2006
Quarterly Report
Excerpted
The Meth Gun is transitioning from a marketing demonstrator prototype, to a beta-test product with a bona-fide law enforcement agency in the Missouri State Highway Patrol, acting as a committed beta-test partner for CDEX. CDEX management anticipates that the "Illicit Drug Detector" could become a significant product portfolio for the company over the next five (5) years. In order for the company to take this product through a successful beta-test program, revise its design, start up a production line, and introduce it into the market by Q2 2007, CDEX must receive additional investment to implement its business plan, successfully complete the pilot test program with MSHP, establish a national and international reseller and distribution network, and enter into production. This will require investment to fund the production start up, marketing and sales initiatives, and provide working capital in order to purchase production materials and parts inventories. If the company is unable to obtain the required funding that it needs through debt or equity financing, in the near term, the potential of the "Illicit Drug Detector" product portfolio cannot be realized.
Readers, here is the link the good Capn is referring to:
Missouri Meth Announcement subject to CDEX report listed below
Form 10QSB for CDEX INC
14-Jun-2006
Quarterly Report
Excerpted
The Meth Gun is transitioning from a marketing demonstrator prototype, to a beta-test product with a bona-fide law enforcement agency in the Missouri State Highway Patrol, acting as a committed beta-test partner for CDEX. CDEX management anticipates that the "Illicit Drug Detector" could become a significant product portfolio for the company over the next five (5) years. In order for the company to take this product through a successful beta-test program, revise its design, start up a production line, and introduce it into the market by Q2 2007, CDEX must receive additional investment to implement its business plan, successfully complete the pilot test program with MSHP, establish a national and international reseller and distribution network, and enter into production. This will require investment to fund the production start up, marketing and sales initiatives, and provide working capital in order to purchase production materials and parts inventories. If the company is unable to obtain the required funding that it needs through debt or equity financing, in the near term, the potential of the "Illicit Drug Detector" product portfolio cannot be realized.
To those who wish to be advised about CDEX 10Q and the "Meth Gun"
Missouri Meth Announcement subject to CDEX report listed below
Form 10QSB for CDEX INC
14-Jun-2006
Quarterly Report
Excerpted
The Meth Gun is transitioning from a marketing demonstrator prototype, to a beta-test product with a bona-fide law enforcement agency in the Missouri State Highway Patrol, acting as a committed beta-test partner for CDEX. CDEX management anticipates that the "Illicit Drug Detector" could become a significant product portfolio for the company over the next five (5) years. In order for the company to take this product through a successful beta-test program, revise its design, start up a production line, and introduce it into the market by Q2 2007, CDEX must receive additional investment to implement its business plan, successfully complete the pilot test program with MSHP, establish a national and international reseller and distribution network, and enter into production. This will require investment to fund the production start up, marketing and sales initiatives, and provide working capital in order to purchase production materials and parts inventories. If the company is unable to obtain the required funding that it needs through debt or equity financing, in the near term, the potential of the "Illicit Drug Detector" product portfolio cannot be realized.
Speaking of meth detection
Missouri Meth Announcement subject to CDEX report listed below
Form 10QSB for CDEX INC
14-Jun-2006
Quarterly Report
Excerpted
The Meth Gun is transitioning from a marketing demonstrator prototype, to a beta-test product with a bona-fide law enforcement agency in the Missouri State Highway Patrol, acting as a committed beta-test partner for CDEX. CDEX management anticipates that the "Illicit Drug Detector" could become a significant product portfolio for the company over the next five (5) years. In order for the company to take this product through a successful beta-test program, revise its design, start up a production line, and introduce it into the market by Q2 2007, CDEX must receive additional investment to implement its business plan, successfully complete the pilot test program with MSHP, establish a national and international reseller and distribution network, and enter into production. This will require investment to fund the production start up, marketing and sales initiatives, and provide working capital in order to purchase production materials and parts inventories. If the company is unable to obtain the required funding that it needs through debt or equity financing, in the near term, the potential of the "Illicit Drug Detector" product portfolio cannot be realized.
I hear you still get to keep your primary domicile in Florida even when you declare bankruptcy Capnmike.
When CDEX becomes insolvent (this month perhaps ?), will you be filing the petition for bankruptcy in your home county? Such a hypster you are Capnmike..you know where the final chapter of this sordid tale will take you and yet you continue without shame.
I guess you just answered how it must feel to have your life savings invested in CDEX.
I certainly would seek professional help if you continue squeezing your head like a grape while chanting a CDEX mantra.
I'm guessing that you are trying to convey to your "loyal following" that you are privy to some type of CDEX insider info that you believe can save your financially strapped ass and are trying so hard to let that cat out the bag with this Microsoft/Spyware nonsense. Anything can happen, huh Capnmike.
Well, let's see how CDEX continues to operate in the upcoming month in such dire financial straits. Anything can happen doncha know.
Perhaps you missed the previous post concerning how many obstacles must be jumped before there is even a remote chance of CDEX beginning any type of successful implementation of the "Meth Gun". Ya know it aint goin' happen Capnmike!
Missouri Meth Announcement subject to CDEX report listed below
Form 10QSB for CDEX INC
14-Jun-2006
Quarterly Report
Excerpted
The Meth Gun is transitioning from a marketing demonstrator prototype, to a beta-test product with a bona-fide law enforcement agency in the Missouri State Highway Patrol, acting as a committed beta-test partner for CDEX. CDEX management anticipates that the "Illicit Drug Detector" could become a significant product portfolio for the company over the next five (5) years. In order for the company to take this product through a successful beta-test program, revise its design, start up a production line, and introduce it into the market by Q2 2007, CDEX must receive additional investment to implement its business plan, successfully complete the pilot test program with MSHP, establish a national and international reseller and distribution network, and enter into production. This will require investment to fund the production start up, marketing and sales initiatives, and provide working capital in order to purchase production materials and parts inventories. If the company is unable to obtain the required funding that it needs through debt or equity financing, in the near term, the potential of the "Illicit Drug Detector" product portfolio cannot be realized.
How's it feel to have your life savings invested in such a speculative and underfunded enterprise? You certainly wouldn't post anything unbiased or post anything you know to be at best, pure hyping regarding CDEX, would ya Capn?
Keep up the pumping Capnmike..looks like CDEX may not be a viable enterprise too much longer.
Missouri Meth Announcement subject to CDEX report listed below
Form 10QSB for CDEX INC
14-Jun-2006
Quarterly Report
Excerpted
The Meth Gun is transitioning from a marketing demonstrator prototype, to a beta-test product with a bona-fide law enforcement agency in the Missouri State Highway Patrol, acting as a committed beta-test partner for CDEX. CDEX management anticipates that the "Illicit Drug Detector" could become a significant product portfolio for the company over the next five (5) years. In order for the company to take this product through a successful beta-test program, revise its design, start up a production line, and introduce it into the market by Q2 2007, CDEX must receive additional investment to implement its business plan, successfully complete the pilot test program with MSHP, establish a national and international reseller and distribution network, and enter into production. This will require investment to fund the production start up, marketing and sales initiatives, and provide working capital in order to purchase production materials and parts inventories. If the company is unable to obtain the required funding that it needs through debt or equity financing, in the near term, the potential of the "Illicit Drug Detector" product portfolio cannot be realized.
Form 10QSB for CDEX INC
14-Jun-2006
Quarterly Report
Excerpted
LIQUIDITY AND CAPITAL RESOURCES
To date, CDEX has incurred substantial losses, and will require financing for working capital to meet its operating objectives. We anticipate that we will require financing on an ongoing basis unless and until we are able to support our operating activities with additional revenues.
As of April 30, 2006, we had negative working capital of $184,237, including $86,698 of cash and cash equivalents. We anticipate the need to raise approximately $3,000,000 over the next eighteen months to satisfy our current budgetary projections. Our continued operations, as well as the implementation of our business plan, therefore will depend upon our ability to raise additional funds through bank borrowings, equity or debt financing. If the company is not successful in raising the working capital, it may default in its payments to its creditors and could result in the filing of bankruptcy protection. Currently, the company has sufficient cash to fund operations through the end of June 2006. The company is actively seeking new investments from its current accredited investors as well as new accredited investors.
RISKS RELATED TO OUR BUSINESS
A HISTORY OF OPERATING LOSSES AND AN ACCUMULATED DEFICIT MAY AFFECT CDEX'S ABILITY TO SURVIVE.
We have a history of operating losses and an accumulated deficit. Since our principal activities to date have been limited to organizational activities, research and development, product development and limited marketing and sales, CDEX has produced only limited revenues. In addition, we have only limited assets. As a result, we cannot be certain that CDEX will continue to generate revenues or become profitable in the future. If we are unable to obtain customers and generate sufficient revenues to operate profitably, our business will not succeed.
CDEX HAS RECEIVED A GOING CONCERN OPINION FROM ITS INDEPENDENT AUDITORS THAT EXPRESSES UNCERTAINTY REGARDING ITS ABILITY TO CONTINUE AS A GOING CONCERN.
We have received a report from our independent auditors for the fiscal year ended October 31, 2005 containing an explanatory paragraph that expresses uncertainty regarding our ability to continue as a going concern due to historical negative cash flow. We cannot be certain that our business plans will be successful or what actions may become necessary to preserve our business. Any inability to raise capital may require us to reduce operations or could cause our business to fail.
LACK OF ADDITIONAL FINANCING COULD PREVENT US FROM OPERATING PROFITABLY WHICH, EVENTUALLY, COULD RESULT IN A TOTAL LOSS OF OUR BUSINESS.
Form 10QSB for CDEX INC
14-Jun-2006
Quarterly Report
Excerpted
ValiMed(TM) Product Line
ValiMed(TM) has transitioned from a beta-test product in to a full-scale production product. Year-on-year revenues are up significantly in 2006, as compared to the three and six month periods of 2005. Management does not expect the revenues from ValiMed(TM) to grow in a linear or predictable manner due to the fact that ValiMed(TM) is a new product that has just been introduced into the market. It is more likely that revenues will be "lumpy" over the next several quarters; with some quarters up and some down. This will continue into the foreseeable future until we have more fully developed our distribution and sales channels and are better able to more precisely predict in which quarters sales will fall. Potential sales for ValiMed(TM) are expected to be in the range of $1.2 to $1.5 million during fiscal year 2006. This sales forecast is based on the minimum sales targets that Baxa must achieve in order to maintain its exclusivity with CDEX, additional ValiMed(TM) sales that CDEX may achieve in markets outside the USA and Canada, additional cuvettes sales for ValiMed(TM), and service support agreements. CDEX believes that ValiMed(TM) could become a significant product portfolio for the company, but management does not guarantee that the sales projections put forth herein will be realized.
In order to reach this potential, CDEX must receive additional investment to implement its business plan, fund its international marketing and sales initiatives, and provide working capital in order to purchase production materials and parts inventories. If the company is unable to obtain the required funding that it needs through debt or equity financing in the near-term, the value potential of the ValiMed(TM) product portfolio over the next eight months cannot be realized.
Form 10QSB for CDEX INC
14-Jun-2006
Quarterly Report
Excerpted
The Meth Gun is transitioning from a marketing demonstrator prototype, to a beta-test product with a bona-fide law enforcement agency in the Missouri State Highway Patrol, acting as a committed beta-test partner for CDEX. CDEX management anticipates that the "Illicit Drug Detector" could become a significant product portfolio for the company over the next five (5) years. In order for the company to take this product through a successful beta-test program, revise its design, start up a production line, and introduce it into the market by Q2 2007, CDEX must receive additional investment to implement its business plan, successfully complete the pilot test program with MSHP, establish a national and international reseller and distribution network, and enter into production. This will require investment to fund the production start up, marketing and sales initiatives, and provide working capital in order to purchase production materials and parts inventories. If the company is unable to obtain the required funding that it needs through debt or equity financing, in the near term, the potential of the "Illicit Drug Detector" product portfolio cannot be realized.
LIQUIDITY AND CAPITAL RESOURCES
To date, CDEX has incurred substantial losses, and will require financing for working capital to meet its operating objectives. We anticipate that we will require financing on an ongoing basis unless and until we are able to support our operating activities with additional revenues.
As of April 30, 2006, we had negative working capital of $184,237, including $86,698 of cash and cash equivalents. We anticipate the need to raise approximately $3,000,000 over the next eighteen months to satisfy our current budgetary projections. Our continued operations, as well as the implementation of our business plan, therefore will depend upon our ability to raise additional funds through bank borrowings, equity or debt financing. If the company is not successful in raising the working capital, it may default in its payments to its creditors and could result in the filing of bankruptcy protection. Currently, the company has sufficient cash to fund operations through the end of June 2006. The company is actively seeking new investments from its current accredited investors as well as new accredited investors.
RISKS RELATED TO OUR BUSINESS
A HISTORY OF OPERATING LOSSES AND AN ACCUMULATED DEFICIT MAY AFFECT CDEX'S ABILITY TO SURVIVE.
We have a history of operating losses and an accumulated deficit. Since our principal activities to date have been limited to organizational activities, research and development, product development and limited marketing and sales, CDEX has produced only limited revenues. In addition, we have only limited assets. As a result, we cannot be certain that CDEX will continue to generate revenues or become profitable in the future. If we are unable to obtain customers and generate sufficient revenues to operate profitably, our business will not succeed.
CDEX HAS RECEIVED A GOING CONCERN OPINION FROM ITS INDEPENDENT AUDITORS THAT EXPRESSES UNCERTAINTY REGARDING ITS ABILITY TO CONTINUE AS A GOING CONCERN.
We have received a report from our independent auditors for the fiscal year ended October 31, 2005 containing an explanatory paragraph that expresses uncertainty regarding our ability to continue as a going concern due to historical negative cash flow. We cannot be certain that our business plans will be successful or what actions may become necessary to preserve our business. Any inability to raise capital may require us to reduce operations or could cause our business to fail.
Our limited operating history makes our future operating results unpredictable rendering it difficult to assess the health of our business or its likelihood of success. The inability to assess these factors could result in a total loss of an investor's investment in CDEX.
CDEX could experience operating losses or even a total loss of our business which, as a result of the foregoing factors, would be difficult to anticipate and could thus cause a total loss of capital invested in CDEX.
THE ABSENCE OF A PERMANENT FULL-TIME CHIEF FINANCIAL OFFICER LEAVES CDEX WITHOUT THE BENEFIT OF THIS TYPE OF EXPERTISE AND CONSISTENT MONITORING OF CONTROLS AND PROCEDURES WHICH A FULL-TIME CHIEF FINANCIAL OFFICER WOULD AFFORD.
In April 2004 we retained a qualified part-time chief financial officer on a consultancy basis. However, we have not retained a permanent, full-time chief financial officer. The responsibilities of the principal accounting and financial officer are currently being handled by our CEO.
LACK OF ADDITIONAL FINANCING COULD PREVENT US FROM OPERATING PROFITABLY WHICH, EVENTUALLY, COULD RESULT IN A TOTAL LOSS OF OUR BUSINESS.
Analytical Spectral Devices, Inc. Moves to Enforce Pharmacy Validation and Inspection Patent
Analytical Spectral Devices, Inc. brings suit against CDEX, Inc.
Boulder, Colo., March 13, 2006 — Analytical Spectral Devices, Inc. (ASD), a manufacturer of rapid, precision, analytical and quality control instruments, announced today that it filed suit against CDEX, Inc. In its Complaint filed in the U.S. District Court in Denver, Colorado, ASD alleges that CDEX’s ValiMed Medical Validation System infringes upon ASD’s U.S. Patent No. 6,771,369. According to CEO and President, David Rzasa, “ASD filed this suit to protect its valuable intellectual property.”
About ASD
Founded in 1990, Analytical Spectral Devices manufactures cost-effective, precision, transportable and field-portable, laboratory-quality Vis/NIR spectrometers, spectroradiometers, spectrophotometers and corresponding software and accessories. ASD’s instruments perform well in a range of environmental conditions, in and outside the laboratory, and have applications in pharmaceutical, nutraceutical, analytical chemistry, mining, grain, food and dairy, remote sensing, pulp and paper industries world-wide. For more information, please contact Amanda Griffin, Analytical Spectral Devices, 5335 Sterling Dr., Suite A, Boulder, CO, 80301; 303/444-6522, 303/444-6825 (fax); www.asdi.com.
Contact: Amanda Griffin
Marketing Communications Manager
Analytical Spectral Devices
303.444.6522
mktg@asdi.com
What's ya going to do about it Monsoonman. Most folks here and elsewhere know what you are all about..what RA is saying about you isn't anything that we don't already know.
I see CDEX is off to a good start this morning. Guess Capnmike and Paige need to get busy with more spamming..might help move the PPS up a few pennies. Come on guys!
Go CDEX!
Capnmike, please save your online huckstering so those who are easily swayed by such rubbish. BTW, have you looked at the stock price of CDEX lately? You really need to step up your efforts if you are to be successful in pumping up the pps of CDEX. I'm sure there are a few suckers out there who may actually buy into your hype and diversion but you had better work fast or CDEX may be insolvent shortly.
Pump it Capnmike, pump it